Tesamorelin

Tesamorelin is a synthetic peptide consisting of 44 amino acids, modified to increase its stability and potency compared to natural growth hormone-releasing hormone. It is notably distinguished as an FDA-approved treatment for reducing excess abdominal fat in patients with HIV-associated lipodystrophy. Unlike synthetic growth hormone injections, this peptide works upstream by signaling the pituitary gland to produce its own growth hormone, which helps preserve the body's natural regulatory feedback loops. Beyond its clinical applications for lipodystrophy, Tesamorelin has gained significant traction in the fitness and longevity communities. It is highly valued for its ability to specifically target visceral adipose tissue—the dangerous fat surrounding internal organs—which is often resistant to diet and exercise alone. Users frequently report improvements in body composition, enhanced recovery, and better metabolic health without the harsh side effects often associated with exogenous HGH therapy.